遠隔患者モニタリング市場は、慢性疾患の増加と技術革新により、2032年までに919億米ドルを超える見込み
SNS INSIDER PVT. LTD.
The global remote patient monitoring market was valued at US$35.47 billion in 2024 and is projected to grow at a compound annual growth rate （CAGR） of 12.69% from 2025 to 2032, reaching US$91.95 billion by 2032. The U.S. RPM market was valued at US$12.76 billion in 2024 and is expected to reach US$32.17 billion by 2032, a CAGR of 12.30% over the same period.
This growth is driven by the rising prevalence of chronic diseases such as heart failure, diabetes, and hypertension, as well as rising healthcare costs worldwide. Patients and healthcare providers are increasingly favoring home-based care. Technological advancements in wearables, IoT, AI, and cloud platforms have enabled real-time data collection, faster anomaly detection, and scalable remote monitoring systems. Policy changes and reimbursement updates in key markets are also driving RPM adoption.
However, challenges remain, with concerns over data security and privacy （HIPAA, GDPR）, varying reimbursement policies across regions, and unequal access to quality connectivity and devices holding back some markets.
Get a free sample report of the Remote Patient Monitoring Market:
https://www.snsinsider.com/sample-request/1788Segmentation Analysis
By Component:
Devices and software dominated the market in 2024, accounting for approximately 56.14% of the total market share. Devices such as blood pressure monitors, blood glucose meters, pulse oximeters, and electrocardiogram trackers are widely adopted, and software platforms are central to data integration and remote diagnostics. The services segment, including device deployment, remote monitoring services, patient onboarding, and technical support, is expected to grow fastest throughout the forecast period as healthcare providers seek turnkey RPM solutions.
By Application:
The cardiovascular disease application accounted for the largest share （36.52%） in 2024 due to the high global burden of hypertension, arrhythmia, and heart failure. These conditions require frequent vital sign monitoring, which RPM efficiently addresses. Diabetes management is expected to be the fastest-growing application segment, driven by the increasing patient population, rising demand for continuous glucose monitoring and connected insulin management, and the growth of mobile health/digital therapeutics in this area.
By End User:
Hospitals will be the largest end-user segment in 2024, accounting for approximately 47.5% of the market share. Robust clinical infrastructure and the need to reduce readmissions make RPM attractive. Home healthcare settings are expected to grow fastest during the forecast period, as more patients, especially elderly and chronically ill patients, prefer home monitoring. Improvements in wearable design, connectivity, and even subscription models are also contributing to this shift.
Regional Analysis
: North America:
This region will lead the RPM market, accounting for approximately 41.2% of global revenue in 2024. The United States is the primary driver, thanks to its advanced digital healthcare infrastructure, supportive reimbursement policies （including remote monitoring and home hospital programs）, high chronic disease burden, and rapid adoption of technology solutions across hospital and home settings.
Asia Pacific:
The Asia Pacific region is growing faster than most other regions, driven by rising middle-class healthcare spending, an expanding digital health ecosystem, widespread smartphone/wearable adoption, and government investments in telehealth infrastructure. Countries such as China, India, and Japan are particularly active. Demand for RPM is growing in rural areas of India and China to bridge gaps in traditional healthcare access.
Access the full report on remote patient monitoring market analysis and outlook:
https://www.snsinsider.com/reports/remote-patient-monitoring-rpm-market-1788.Recent Trends:
August 2024 - The Masimo W1 Medical Watch received FDA 510（k） clearance, illustrating how AI-driven wearables are enhancing RPM capabilities, particularly in continuous monitoring and early detection use cases. April 2024 - The U.S. Centers for Medicare and Medicaid Services （CMS） approved 133 hospital-at-home programs in 37 states, formally recognizing home care solutions and remote patient monitoring as viable alternatives to hospitalization.
Mid-2024 - Several health systems have deployed AI-assisted RPM platforms that integrate anomaly detection, alerts, and predictive analytics to monitor post-surgical and chronic disease patients, resulting in measurable reductions in hospital readmissions in pilot programs.
Related Reports
Wearable Medical Devices Market Report:
https://www.snsinsider.com/reports/wearable-medical-devices-market-1084 Internet of Things in Healthcare Market:
https://www.snsinsider.com/reports/internet-of-things-in-healthcare-market-2617配信元企業：SNS INSIDER PVT. LTD.
プレスリリース詳細へドリームニューストップへ
記事提供：DreamNews
